Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
Author:
Funder
Beijing Municipal Commission of Education
Publisher
Elsevier BV
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine
Reference40 articles.
1. Cross-species transmission of the newly identified coronavirus 2019-nCoV;Ji;J Med Virol,2020
2. 2019 novel coronavirus (2019-nCoV) outbreak: A new challenge;Lupia;J Global Antimicrob Resis,2020
3. Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis2020:101608.
4. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;N Engl J Med,2020
5. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2;Zhou;Cell Discov,2020
Cited by 221 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fufang Luohanguo Qingfei granules reduces influenza virus susceptibility via MAVS-dependent type I interferon antiviral signaling;Journal of Ethnopharmacology;2024-04
2. Traditional uses, botany, phytochemistry, and pharmacology of Lonicerae japonicae flos and Lonicerae flos: A systematic comparative review;Journal of Ethnopharmacology;2024-03
3. Herbal Substances with Antiviral Effects: Features and Prospects for the Treatment of Viral Diseases with Emphasis on Pro-Inflammatory Cytokines;Current Medicinal Chemistry;2024-02
4. Antidiabetic effects and mechanisms of Cyclocarya paliurus leaf flavonoids via PIK3CA;Journal of Functional Foods;2024-02
5. A bibliometric analysis of phenolic acids over the last five years;Biocatalysis and Agricultural Biotechnology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3